Menopausal Hot Flashes - Pipeline Review, H2 2014

Published: Aug, 2014 | Pages: 44 | Publisher: Global Markets Direct
Industry: Healthcare | Report Format: Electronic (PDF)

Menopausal Hot Flashes - Pipeline Review, H2 2014

Summary

Global Markets Direct's, 'Menopausal Hot Flashes - Pipeline Review, H2 2014', provides an overview of the Menopausal Hot Flashes's therapeutic pipeline.

This report provides comprehensive information on the therapeutic development for Menopausal Hot Flashes, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Menopausal Hot Flashes and special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global therapeutic landscape of Menopausal Hot Flashes
- The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities 
- The report reviews key players involved in the therapeutics development for Menopausal Hot Flashes and enlists all their major and minor projects
- The report summarizes all the dormant and discontinued pipeline projects 
- A review of the Menopausal Hot Flashes products under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- A detailed assessment of monotherapy and combination therapy pipeline projects
- Coverage of the Menopausal Hot Flashes pipeline on the basis of target, MoA, route of administration and molecule type
- Latest news and deals relating related to pipeline products

Reasons to buy

- Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop strategic initiatives by understanding the focus areas of leading companies
- Identify and understand important and diverse types of therapeutics under development for Menopausal Hot Flashes
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Devise corrective measures for pipeline projects by understanding Menopausal Hot Flashes pipeline depth and focus of Indication therapeutics
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
- Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline

 Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Menopausal Hot Flashes Overview 6
Therapeutics Development 7
Pipeline Products for Menopausal Hot Flashes - Overview 7
Pipeline Products for Menopausal Hot Flashes - Comparative Analysis 8
Menopausal Hot Flashes - Therapeutics under Development by Companies 9
Menopausal Hot Flashes - Pipeline Products Glance 10
Clinical Stage Products 10
Early Stage Products 11
Unknown Stage Products 12
Menopausal Hot Flashes - Products under Development by Companies 13
Menopausal Hot Flashes - Companies Involved in Therapeutics Development 14
Amgen Inc. 14
Eisai Co., Ltd. 15
Pherin Pharmaceuticals, Inc. 16
Menopausal Hot Flashes - Therapeutics Assessment 17
Assessment by Monotherapy Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
RAD-1901 - Drug Profile 26
Product Description 26
Mechanism of Action 26
R&D Progress 26
Salubrin-HF - Drug Profile 28
Product Description 28
Mechanism of Action 28
R&D Progress 28
AMG-334 - Drug Profile 29
Product Description 29
Mechanism of Action 29
R&D Progress 29
MNGX-100 - Drug Profile 30
Product Description 30
Mechanism of Action 30
R&D Progress 30
HBN-2 - Drug Profile 31
Product Description 31
Mechanism of Action 31
R&D Progress 31
homatropine methylbromide - Drug Profile 32
Product Description 32
Mechanism of Action 32
R&D Progress 32
Menopausal Hot Flashes - Recent Pipeline Updates 33
Menopausal Hot Flashes - Dormant Projects 35
Menopausal Hot Flashes - Discontinued Products 36
Menopausal Hot Flashes - Product Development Milestones 37
Featured News & Press Releases 37
Sep 26, 2012: Eaton Scientific Highlights International Potential For Tropine 3 As Globally Accepted Non-Hormonal Treatment For Hot Flash Symptoms 37
Sep 25, 2012: Eaton Scientific Provides Outline On Market Potential Of Tropine 3 For Non-Hormonal Treatment Of Hot Flashes 37
Sep 13, 2012: Eaton Scientific Teams Up With Urologist Dr Jennifer Berman To Advance Tropine 3 Trials And Marketing 37
Sep 06, 2012: Eaton Scientific Completes Study Protocol For Phase I/II Study Of Tropine 3 For Treatment Of Hot Flashes 38
Sep 04, 2012: Eaton Scientific Enters Agreement With RoxSan Pharmacy To Provide Tropine 3 For Upcoming Clinical Trial Participants 38
Aug 28, 2012: Eaton Scientific Announces Clinical Trial Plans For Tropine 3 For Treatment Of Hot Flashes In Menopausal Women 39
May 03, 2011: Pfizer Announces Results From Phase III Efficacy Sub-Study Of PRISTIQ 39
Jun 19, 2010: Radius Presents Positive Phase IIa Study Results Of RAD1901 In Reducing Menopausal Hot Flashes 40
Jun 08, 2008: Radius Presents Preclinical Study Of RAD1901 At The Endocrine Society 2007 Annual Meeting 41
Appendix 43
Methodology 43
Coverage 43
Secondary Research 43
Primary Research 43
Expert Panel Validation 43
Contact Us 44
Disclaimer 44

List of Tables
Number of Products under Development for Menopausal Hot Flashes, H2 2014 7
Number of Products under Development for Menopausal Hot Flashes - Comparative Analysis, H2 2014 8
Number of Products under Development by Companies, H2 2014 9
Comparative Analysis by Clinical Stage Development, H2 2014 10
Comparative Analysis by Early Stage Development, H2 2014 11
Comparative Analysis by Unknown Stage Development, H2 2014 12
Products under Development by Companies, H2 2014 13
Menopausal Hot Flashes - Pipeline by Amgen Inc., H2 2014 14
Menopausal Hot Flashes - Pipeline by Eisai Co., Ltd., H2 2014 15
Menopausal Hot Flashes - Pipeline by Pherin Pharmaceuticals, Inc., H2 2014 16
Assessment by Monotherapy Products, H2 2014 17
Number of Products by Stage and Target, H2 2014 19
Number of Products by Stage and Mechanism of Action, H2 2014 21
Number of Products by Stage and Route of Administration, H2 2014 23
Number of Products by Stage and Molecule Type, H2 2014 25
Menopausal Hot Flashes Therapeutics - Recent Pipeline Updates, H2 2014 33
Menopausal Hot Flashes - Dormant Projects, H2 2014 35
Menopausal Hot Flashes - Discontinued Products, H2 2014 36